Injection device maker Curexel Technologies raises seed funding led by IN44 Capital
LinkedIn Announcement Curexel Technologies
Bengaluru-based Curexel Technologies has raised a seed investment round led by IN44 Capital , with participation from Peaceful Progress, Venture Center and Bangalore Bioinnovation Centre.Founded in 2023 by Kedar Badnikar, Vasudha Narasimha Swamy and Shreyas N.J, Curexel Technologies develops patented, painless intradermal drug delivery systems. The firm’s product platform is designed for vaccines, pain management, growth hormones, IVF, and diabetes care.The company plans to use the new funds to advance its research and development efforts and progress toward regulatory approval milestones.
Want to receive such news items in your inbox? Click Here to sign up for a trial.